Aug. 8 (Bloomberg) -- German stocks rose. Schwarz Pharma AG shares climbed after the drugmaker said an experimental diabetes treatment met the main goal of its final study.

Mobilcom AG and Freenet.de AG also advanced.

The DAX Index added 23.45, or 0.5 percent, to 4850.63 as of 11:15 a.m. in Frankfurt. All but eight of the benchmark's 30 members advanced. The HDAX Index of the country's 110 biggest companies gained 0.4 percent to 2501.84.

Schwarz Pharma AG jumped 2.10 euros, or 5.3 percent, to 42 euros. Germany's fifth-largest publicly traded drugmaker said its experimental Lacosamide drug was safe and reduced diabetic nerve pain in arms and legs compared with placebo in a study that's in the last of three sets of clinical trials generally required for regulatory approval.

Bayer AG rose 41 cents, or 1.4 percent, to 30.33 euros. The inventor of aspirin will begin late-stage clinical trials on its clot-busting drug BAY 59-7939 in the fourth quarter after results showed it prevented deep-vein thrombosis in hip- and knee- replacement patients.

Mobilcom, Germany's second-largest reseller of mobile-phone services, increased 78 cents, or 3.9 percent, to 20.71 euros. Second-quarter profit surged 61 percent after it added customers and revenue at the Freenet.de Web unit increased. Mobilcom reiterated a March forecast that 2005 earnings before interest, tax, depreciation and amortization will rise as much as 20 percent from 2004.

Freenet.de, an Internet-access provider owned 50.4 percent by Mobilcom, climbed 96 cents, or 4.3 percent, to 23.50 euros. Second-quarter sales increased 63 percent to 178.3 million euros.

Lufthansa added 20 cents, or 1.93 percent, to 10.68 euros. Europe's second-biggest airline is scheduled to release traffic figures for July. Larger rival Air France-KLM Group today said passenger traffic rose 9.2 percent last month as travel to North America and Asia increased.

Separately, Lufthansa will announce a new pricing system this month for discount tickets to challenge low-fare carriers in Europe, Frankfurter Allgemeine Zeitung reported, without saying where it got the information.

The following stocks are rising or falling. Stock symbols are in parentheses after the company names.

Bilfinger Berger AG (GBF GY), Germany's second-largest builder, rose 73 cents, or 1.7 percent, to 43.29 euros. Analysts at UBS AG raised the share-price forecast by 13 percent to 51 euros.

Degussa AG (DGX GY), the world's biggest maker of specialty chemicals, dropped 44 cents, or 1.2 percent, to 36.06 euros. Second-quarter profit unexpectedly fell 5.9 percent to 96 million euros ($118 million) on higher interest payments and restructuring costs. Analysts surveyed by Bloomberg expected 117 million euros.

Dyckerhoff AG (DYK GY), Germany's second-biggest cement maker, gained 52 cents, or 1.7 percent, to 31.99 euros. The company said profit tripled to 27 million euros in the first half, helped by sales in Easter Europe and the U.S.

MorphoSys AG (MOR GY) climbed 1 euro, or 2.8 percent, to 36.18 euros. The supplier of antibodies used to develop new drugs said it received an undisclosed payment for supplying Novartis AG with custom-made cancer antibodies.

ProSiebenSat.1 Media AG (PSM GY) fell 15 cents, or 1 percent, to 14.70 euros. The German publisher Verlagsgruppe Georg Holtzbrinck GmbH will raise an objection with Germany's Federal Cartel Office over Axel Springer AG buying a majority of ProSiebenSat.1, the Sueddeutsche Zeitung reported yesterday.

Here arises a ``big media power,'' said Michael Grabner, the deputy managing director of Holtzbrinck, whose company wasn't allowed to buy the daily Berliner Zeitung last year.

To contact the reporter on this story: Margo Towie in Brussels at mtowie@bloomberg.net.

Last Updated: August 8, 2005 05:18 EDT